Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ondansetron Hydrochloride Orally Disintegrating Tablets

Approval Number

国药准字H20080300

Company国药集团川抗制药有限公司

Registration Date

November 4, 2022

Previous Approval Numbers

国药准字H20080300

Drug Information

Generic Name

盐酸昂丹司琼口腔崩解片

Brand Name

瞬吉

Dosage Form

片剂

Strength

8mg(以昂丹司琼计)

Drug Type

化学药品

Registration Date

November 4, 2022

Company Information

Applicant Company

Company Name国药集团川抗制药有限公司

Company Address

成都市高新区西部园区新文路2号

Manufacturing Company

Company Name国药集团川抗制药有限公司

Company Address

成都市高新区西部园区新文路2号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy